hrs4r
Quiero donar
Firma
ANNA BAHÍ-SALAVEDRA
Posición
Investigador/a Post-doctoral – R2
Investigadores/as Post-doctorales – R2

Projectes

Codi oficial: La Marató 201912-31 Data inicio:30/09/2020 Data fi: 31/01/2024 Investigador/a principal: XAVIER ALDEGUER MANTE Organisme finançador: FUNDACIO LA MARATO TV3

Publicacions

Lluansí A, Llirós M, Carreras-Torres R, Bahí A, Capdevila M, Feliu A, Vilà-Quintana L, Elias-Masiques N, Cueva E, Peries L, Torrealba L, Miquel-Cusachs JO, Sàbat M, Busquets D, López C, Delgado-Aros S, Garcia-Gil LJ, Elias I, Aldeguer X

Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study.

Plos One, 2024, 19 dx.doi.org/10.1371/journal.pone.0297836
Taboada-López, S, Malagón, M, Amoedo, J, Ramió-Pujol, S, Busquets, D, Bahi, A, Gilabert, P, Rodríguez-Alonso, L, Mañosa, M, Cañete, F, Torres, PF, Morales, VJ, Delgado-Guillena, PG, Domenech, E, Guardiola, J, Serra-Pagés, M, Garcia-Gil, LJ, Aldeguer, X

A faecal microbial signature, in combination with faecal calprotectin, to optimise endoscopic activity monitoring in Crohn's Disease

JOURNAL OF CROHNS & COLITIS, 2024, 18, 2142-2142
Oliver L, Ramió-Pujol S, Amoedo J, Malagón M, Serrano M, Bahí A, Lluansí A, Torrealba L, Busquets D, PARDO, L., Serra-Pagès M, Aldeguer X, Garcia-Gil J

A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples

FRONTIERS IN MICROBIOLOGY, 2021, 12, 639948-639948 dx.doi.org/10.3389/fmicb.2021.639948
Lluansí A, Llirós M, Oliver L, Bahí A, Elias-Masiques N, Gonzalez M, Benejam P, Cueva E, Termes M, Ramió-Pujol S, Malagón M, Amoedo J, Serrano M, Busquets D, Torreabla L, Sabat M, Buxó M, Cambra M, Serra-Pagès M, Delgado-Aros S, García-Gil LJ, Elias I, Aldeguer X

In vitro Prebiotic Effect of Bread-Making Process in Inflammatory Bowel Disease Microbiome

FRONTIERS IN MICROBIOLOGY, 2021, 12, 716307-716307 dx.doi.org/10.3389/fmicb.2021.716307
Busquets D, Oliver L, Amoedo J, Ramió-Pujol S, Malagón M, Serrano M, Bahí A, Capdevila M, Lluansí A, Torrealba L, Peries L, Chavero R, Gilabert P, Sàbat M, Guardiola J, Serra-Pagès M, Garcia-Gil J, Aldeguer X

RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment

INFLAMMATORY BOWEL DISEASES, 2021, 27, 63-66 dx.doi.org/10.1093/ibd/izab273
Malagón M, Ramió-Pujol S, Serrano M, Amoedo J, Oliver L, Bahí A, Miquel-Cusachs JO, Ramirez M, Queralt-Moles X, Gilabert P, Saló J, Guardiola J, Piñol V, Serra-Pagès M, Castells A, Aldeguer X, Garcia-Gil LJ

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population

Plos One, 2020, 15 dx.doi.org/10.1371/journal.pone.0243158
Malagón M, Ramió-Pujol S, Serrano M, Serra-Pagès M, Amoedo J, Oliver L, Bahí A, Mas-de-Xaxars T, Torrealba L, Gilabert P, Miquel-Cusachs JO, García-Nimo L, Saló J, Guardiola J, Piñol V, Cubiella J, Castells A, Aldeguer X, Garcia-Gil J

Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49, 1410-1420 dx.doi.org/10.1111/apt.15251
Busquets D, Mas-de-Xaxars T, López-Siles M, Martínez-Medina M, Bahí A, Sàbat M, Louvriex R, Miquel-Cusachs JO, Garcia-Gil JL, Aldeguer X

Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease.

JOURNAL OF CROHNS & COLITIS, 2015, 9, 899-906 dx.doi.org/10.1093/ecco-jcc/jjv119

Formulari de contacte

Conoce el IDIBGI!

menu